Systematic review finds plant-based therapies beneficial for liver protection, suggesting new treatment options.
AbstractLiver diseases remain a major global health burden, driven by factors such as alcohol consumption, viral infections, drug-induced toxicity, and metabolic disorders. Conventional pharmacological treatments are often limited by adverse effects, high costs, and variable efficacy, prompting growing interest in plant-based alternatives. This systematic review aims to evaluate the hepatoprotective potential of medicinal plants and their bioactive constituents, with a focus on mechanisms of action, preclinical and clinical evidence, and therapeutic relevance. A comprehensive literature search was conducted across major scientific databases, including PubMed, Scopus, and Web of Science, selecting studies that investigated plant-derived extracts or compounds with demonstrated liver-protective activity. such as Silybum marianum, Curcuma longa, Phyllanthus niruri, and Andrographis paniculata, exhibit significant hepatoprotective effects. These effects are primarily mediated through antioxidant, anti-inflammatory, anti-fibrotic, and detoxification pathways, including modulation of oxidative stress markers, cytokine production, and hepatic enzyme activity. Additionally, certain phytochemicals, such as flavonoids, terpenoids, and polyphenols, play a crucial role in liver regeneration and cellular protection. Despite promising preclinical data, clinical validation remains limited and heterogeneous. plant-based therapies represent a valuable and promising approach for hepatoprotection, offering potential complementary or alternative strategies in the management of liver disorders. Keywords Antioxidant, Cirrhosis, Hepatoprotection, Liver function, Metabolic disorders
No takes yet. Share an insight, caveat, or question.
Moni Rawat * (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: